BusinessHealthMedical Devices

Transdermal Drug Delivery System Market by Size, Growth, Opportunity and Forecast to 2027

Selbyville, Delaware this Global Transdermal Drug Delivery System report studies the industry based on one or more segments covering key players, types, applications, products, technology, end-users, and regions for historical data as well as provides forecasts for next few years.

Factors such as increased pervasiveness of chronic conditions and cardiovascular diseases such as acute myocardial infraction, angina pectoris, and atherosclerosis have impelled the demand for innovative drug delivery systems, which in turn is driving the market growth. The transdermal dosage forms are used as a substitute of the conventional dosage forms as it provides benefits such as action termination option in case of harmful effects, simple mode of administration, and controlled zero ordered absorption, which has bolstered its application for treating chronic conditions.

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2689391/?utm_source=Marketwatch.com&utm_medium=AN    

Growing demand for noninvasive drug delivery devices along with rising adoption of self-administration practices of drugs is further aiding the expansion of transdermal drug delivery system market. However, high costs associated with the development of drug delivery systems and rising concerns regarding drug recalls & failures of transdermal drug delivery system may act as restraining factors to the growth of the overall market in the ensuing years.

For the uninitiated, transdermal drug delivery system comprises of drugs with a fixed surface area which provides a set amount of dosage to the skin at a pre-determined rate.

In terms of type, the market is divided into transdermal semisolids and transdermal patches. The transdermal patch segment, which comprises of micro needle patches, reservoir membrane patches, matrix patches, and drug-in-adhesive patches, held a substantial market share in 2019. Moreover, it is slated to record a robust CAGR during the analysis period.

Speaking of end user scope, the market is categorized into home care settings, hospitals & clinics, and others. Hospitals & clinics segment accounted for a considerable share in 2019 and is slated to grow substantially over the forecast timeframe.

Based on the application spectrum, the market is divided into cardiovascular diseases, hormonal applications, central nervous system disorders, and pain management. Pain management segment led the market in terms of shares in 2019 and is projected to witness a substantial growth rate during the anticipated timeframe.

The leading organizations in global transdermal drug delivery system market are Lavipharm S.A., Purdue Pharma L.P., Luye Pharma Group, Hisamitsu Pharmaceutical Company Incorporation, Boehringer Ingelheim International GmbH, Mylan N.V., Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson Services Incorporation, and Novartis AG among others.

Question and Answer: Global Transdermal Drug Delivery System Market

Q1) What factors are driving the growth of global transdermal drug delivery system market?

Answer: Increased pervasiveness of chronic conditions and cardiovascular diseases, growing demand for noninvasive drug delivery devices and rising adoption of self-administration practices of drugs are the key factors driving the global transdermal drug delivery system market growth.

Q2) How will rising prevalence of chronic and cardiovascular disorders contribute towards the growth of transdermal drug delivery system industry?

Answer: Transdermal dosage forms are used as a substitute of the conventional dosage forms as it provides benefits such as action termination option in case of harmful effects, simple mode of administration, and controlled zero ordered absorption, which is enhancing their application for treating chronic conditions.

Q3) Which companies formulate the competitive landscape of global transdermal drug delivery system market?

Answer: Lavipharm S.A., Purdue Pharma L.P., Luye Pharma Group, Hisamitsu Pharmaceutical Company Incorporation, Boehringer Ingelheim International GmbH, Mylan N.V., Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson Services Incorporation, and Novartis AG are some of the key players participating in transdermal drug delivery system industry.

Complete Report At: https://www.marketstudyreport.com/reports/transdermal-drug-delivery-system-market-forecast-to-2027?utm_source=Marketwatch.com&utm_medium=AN

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: [email protected]

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close